• Home
    • StockRanks™
    • Platform
        • Research & Discuss
        • Editorial & Community
        • Learn & Improve
        • Webinars & Masterclasses
        • Stockopedia Academy
    • Reviews
    • Pricing
    Get startedLog in
    SectorsHealthcareBiotechnology & Medical ResearchAgenus
    Picture of Agenus logo

    AGEN — Agenus News Story

    $6.730.000.00%
    us flag iconLast trade - 00:00
    HealthcareSpeculativeSmall CapTurnaround
    • Market Cap
      $304.51m
    • Enterprise Value
      $478.50m
    • Revenue
      $114.20m
    • Quality
    • Value
    • Momentum
    • StockRank™
    • StockReport™
    • Accounts
      • Balance sheet
      • Income statement
      • Cashflow statement
      • Dividend summary
    • News
    • AGEN Dividends
    StockReport™
    Balance sheet
    Income statement
    Cashflow
    News
    AGEN Dividends
    All News

    NASDAQ RESUMED AT 10:48 AM

    Picture of Agenus logoAgenus
    19/12/2025 15:48
    NASDAQ RESUMED  AGEN.O  AT 10:48 AM
    

    Recent news on Agenus

    See all news
    • Brief: Agenus Reports 72% Of Patients With Locally Advanced Dmmr Colon Cancer Had No Cancer Remaining At Surgery Following Six Weeks Of Bot+Bal In Phase 2 Neoasis Study At Esmo 2026

      25/10/2026 11:01
    • Brief: Armenia Grants First Marketing Authorizations For Agenus’ Bot+Bal In Previously Treated Mss Metastatic Colorectal Cancer

      08/10/2026 13:08
    • Brief: Agenus - Unit Enters Second Loan Modification Agreement With Ocean 1181 On Aug 12, 2026 - SEC Filing

      18/08/2026 21:36
    • Agenus Inc reports results for the quarter ended June 30 - Earnings Summary

      07/08/2026 22:31
    • Agenus Q2 revenue rises on access and royalty income

      06/08/2026 12:44

    Company

    • About us
    • Careers
    • Product Guide

    Our Coverage

    • Countries
    • Sectors
    • Ratios

    Top Stocks

    • UK Stocks
    • Australian Stocks
    • US Stocks

    Legals

    • Privacy Policy
    • Terms & Conditions
    • Disclaimer & FSG
    • Cookies
    Trustpilot
    Select a country/region:


    © Stockopedia 2026, Refinitiv, Share Data Services.

    *Past performance is no indicator of future performance, and testimonials are provided by third parties for informational purposes only and are not intended and should not be taken to be financial product advice. Performance returns are based on hypothetical scenarios and do not represent an actual investment.

    This site cannot substitute for professional investment advice or independent factual verification. To use Stockopedia, you must accept our Terms of use, Privacy and Disclaimer & FSG. All services are provided by Stockopedia Ltd, United Kingdom (company number 06367267). For Australian users: Stockopedia Ltd, ABN 39 757 874 670 is a Corporate Authorised Representative of Daylight Financial Group Pty Ltd ABN 77 633 984 773, AFSL 521404.